ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report

May 12, 2000

Tom Curran Becomes AACR President, Hong Is President-Elect; Attendance 13,000.

April 14, 2000

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Cancer Care Act Introduced In Senate.

April 18, 2008

US Could Lose Leadership In Research If NIH Budget Is Cut, ASCO President Says

June 2, 1995